Ahmedabad Times

Shares of Biocon jumped greater than 6% on Tuesday, on observe to file the sharpest single day surge in 18 months, as Viatris-owned Mylan is ready to promote as much as 9.2 crore shares price as much as Rs 3,481 crore, exiting the Indian drugmaker.

Biocon shares jumped greater than 6% to commerce at Rs 436.15 apiece on Tuesday. If the inventory manages to carry on to the good points until the tip of the session, then as we speak would mark its greatest day since January, 2025.

Mylan, which is a part of international healthcare firm Viatrisplanned to promote the stake which represents 5.64% of Biocon’s excellent shares, in keeping with a time period sheet as per a Reuters report. The ground value of the provide was fastened at Rs 378.50 per share, implying a reduction of almost 8% to Biocon’s earlier closing value of Rs 410.95 per share. The report added that Citigroup World Markets India and Jefferies India had been the joint bookrunners and brokers for the deal.

In the meantime, round 4.4 crore shares, or 2.7% fairness, modified fingers in a block deal within the early buying and selling hours, adopted by one other block deal that noticed 4.6 crore shares change fingers, ET Now reported. This brings the entire variety of shares which had been traded in block offers to almost 9 crore, almost matching what Mylan was anticipated to promote, though the vendor within the block offers that passed off within the morning is but to be ascertained.

Additionally Learn | Mylan to promote as much as $363 million stake in India’s Biocon, time period sheet reveals

Biocon shareholding sample

Mylan held 5.64% stake in Biocon on the finish of the monetary yr 2026, in keeping with knowledge on the corporate’s shareholding sample accessible on NSE. Promoter Name Mazumdar Shaw held round 30% stake, whereas Glentec Worldwide held round 15% stake.

Round 39 mutual funds held over 15% stake within the firm, whereas insurance coverage firms held greater than 6% stake. Almost 3.74 lakh retail shareholders in the meantime owned 6% stake within the firm, as of March 31, 2026.

Biocon share value

Biocon shares sharply jumped greater than 6% on Tuesday to commerce at Rs 436.15 apiece on NSE, the best stage seen since Could 29 this yr. The shares of the corporate have jumped round 7% in a single week and 4% in a single month.
The shares of the drugmaker have gained round 12% in 2026 to date. In the long run, Biocon shares have delivered 14% returns over one yr, 66% returns over three years and 9% returns over 5 years.Additionally Learn | Sensex falls 500 factors, Nifty slips under 24,100 as US-Iran battle escalates. What lies forward?

(Disclaimer: Suggestions, solutions, views and opinions given by the consultants are their very own. These don’t characterize the views of The Financial Occasions)